相关实验视频

Updated: Jan 10, 2026

Xenopus laevis as a Model to Identify Translation Impairment

Xenopus laevis as a Model to Identify Translation Impairment

Published on: September 27, 2015

4E-BP作为神经疾病的翻译调节剂:分子机制和治疗潜力

Sindhu S Baskarapantula¹, Venkata Surya Kumar¹, Priyajit Changdar¹

¹Center for Molecular Neurosciences, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, India.

Molecular neurobiology

|November 25, 2025

概括

4E-结合蛋白 (4E-BPs) 调节神经系统功能至关重要的蛋白质翻译. 它们的失调与神经疾病有关,突出显示4E-BPs是潜在的治疗点和生物标志物.

科学领域:

神经科学是一个神经科学.
分子生物学分子生物学
生物化学生物化学

背景情况:

蛋白质翻译对人类神经系统至关重要.
4E-结合蛋白 (4E-BPs) 是通过eIF4E启动翻译的关键调节者.
失调的4E-BP活性与各种神经和自身免疫疾病有关.

研究的目的:

审查4E-BPs在中枢神经系统 (CNS) 中的作用.
在突触可塑性和认知方面探索4E-BP同类,特别是中枢神经系统主导的4E-BP2.
检查4E-BP在疾病发病过程中的参与及其作为治疗点的潜力.

主要方法:

综合文献综述,重点关注中枢神经系统中的4E-BP功能.
分析4E-BP同类 (4E-BP1,4E-BP2,4E-BP3) 在神经系统疾病中的作用.
检查mTOR/4E-BP信号通路及其调制.

主要成果:

4E-BP2显示中枢神经系统的特定优势,影响突触可塑性和认知功能.
机械洞察力揭示了4E-BP如何对共同和特定疾病特征作出贡献.
mTOR/4E-BP轴是一个关键的途径,与神经疾病的发病有关.

结论:

4E-BPs是中枢神经系统中蛋白质翻译的关键调节者,在神经健康和疾病中起着重要的作用.
4E-BP2是中枢神经系统功能,突触可塑性和认知过程中的关键参与者.
调节mTOR/4E-BP轴为神经疾病带来治疗机会和挑战,4E-BP是有前途的生物标志物.

关键词:

在 4E-BP1 中.在 4E-BP2 中.在 4E-BP3 中.神经退行发生神经退行.神经发育障碍神经发育障碍蛋白质的翻译是蛋白质的翻译.

更多相关视频

Implantation of Miniosmotic Pumps and Delivery of Tract Tracers to Study Brain Reorganization in Pathophysiological Conditions

Implantation of Miniosmotic Pumps and Delivery of Tract Tracers to Study Brain Reorganization in Pathophysiological Conditions

Published on: January 18, 2016

Optogenetic Phase Transition of TDP-43 in Spinal Motor Neurons of Zebrafish Larvae

Optogenetic Phase Transition of TDP-43 in Spinal Motor Neurons of Zebrafish Larvae

Published on: February 25, 2022

相关概念视频

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...